Účinnost od 31.3.2006 xx 22.9.2007 (xx xxxxxx x. 230/2007 Xx.)
Xxxxxxx č. 6 x xxxxxxxx x. 26/2001 Xx.
Xxxx 1
Seznam xxxxxxxxxxxxx xxxxxx povolených x xxxxxxxxxxxx xxxxxxxxxxxx, xxxxxxxx přípustné koncentrace, xxxxxxxxx na xxxxxxx xxxxxxxxx konzervačních xxxxxx x xxxxxxxx xxxxxxx
Xx xxxxxxxxxxx xxxxxxx se xxxxxxxx x soli xxxxx, xxxxxxxxx v xxxxxxx x. 6. x xx xxxx xxxxxxxx, xxxxx, vápenaté, xxxxxxxxx, xxxxxx, ethanolaminové x dále xxxxxxxx, xxxxxxx, sírany, xxxxxx x xxxxxx-, xxxxx-, xxxxxx, xxxxxxxxx-, xxxxx-, xxxxxxxx- a xxxxxxxxxxx.
Xxxxx xxxxxxxx xxxxxxxx (+) xxx xxxxxxxx xx xxxxxxxxxxxx xxxxxxxxxx rovněž x xxxxxxxxxxx xxxx, xxx xx v xxxxxxx č. 6 xxxxxxx, xxx xxx xxx xxxxxxxxxx xxxxx, xxxxx xxxx zřejmé x xxxxxxxxxxx xxxxxx, xxxxxxxx xxxxx použití xxxxxxxxxxxx prostředku, xxxxxxxxx xxxx xxxxxxxxxxx xx xxxxx xxxx xxxxxxx xxxxx xxxxx do xxxxxxx.
Xxxxxxx xxxxx xxxxxxxxx xx xxxxxxxxx kosmetického xxxxxxxxxx xxxxx xxx xxxxxx xxxxxxxxxxxxxxx vlastnosti x mohou xxx xxxxxxxxx konzervaci výrobku. Xxx například x xxxx éterických xxxxx x některé xxxxxxxx. Xxxx xxxxx xxxxxx xxxxxxxx do přílohy x. 6.
Všechny finální xxxxxxxxxx xxxxxxxxxx, xxxxx xxxxxxxx xxxxxxxxxxx xxxx xxxxx xxxxxxxxxxx xxxxxxxxxx, xxxx xxx xx xxxxx xxxxxxxx varováním "xxxxxxxx xxxxxxxxxxx", pokud xxxxxxxxxxx xxxxxxxxxxxx ve xxxxxxxx xxxxxxx xxxxxxxx 0,05 procent.
___________________________________________________________________________________________
Ref. Látka Maximální Omezení x xxxxxxxxx Xxxxxxxx použití
číslo povolená xxxxxxxxxxx x xxxxxxxx, která xxxx
xxx xxxxxxxxx na obalu
___________________________________________________________________________________________
a x x x e
___________________________________________________________________________________________
1 Xxxxxxxx benzoová•; 0,5 % x přepočtu xx xxxxxxxx
/Xxxxxxx acid/°, xxxx soli
a xxxxxx (+)
___________________________________________________________________________________________
2 Xxxxxxxx xxxxxxxxxx•; 2 % v xxxxxxxx xx xxxxxxxx
/Xxxxxxxxx acid/°a xxxx xxxx
___________________________________________________________________________________________
3 Xxxxxxxx salicilová•; 0,5 % x xxxxxxxx xx xxxxxxxx Xxxxx xxx xxxxxxx xx xxxxxxx xxx Xxxxxxxxxx xxx xxxx
/Xxxxxxxxx xxxx /°x xxxx xxxx xx 3 let s xxxxxxxx šamponu. do 3 xxx (1).
xxxx (+)
___________________________________________________________________________________________
4 Kyselina xxxxxxx (xxxx- 0,6 % x xxxxxxxx xx xxxxxxxx
-2,4-xxxxxxx kyselina)•;
/Sorbic xxxx (xxxx-2,4-
-xxxxxxx xxxx)/°x xxxx
xxxx (+)
___________________________________________________________________________________________
5 Xxxxxxxxxxx•; 0,2 % (xxxx xxxxxxxxxx pro Xxxxxxxx v xxxxxxxxxxxxxx
/Xxxxxxxxxxxx/°x xxxxxxx úst) aerosolů (xxxxxxxx).
xxxxxxxxxxxxxxx• ; 0,1 % (xxxxxxxxxx xxx xxxxxxx
/Xxxxxxxxxxxxxxxx/°(+) xxx) x xxxxxxxx xx xxxxx
xxxxxxxxxxx
___________________________________________________________________________________________
6 xxxxxxx neobsazena
___________________________________________________________________________________________
7 Xxxxxxx.-2-xx(x-xxxxx- 0,2 % x xxxxxxxx na xxxxx
xxxxx)•; /Xxxxxxxx-2-
-xx(x-xxxxxxxxxxxx/°)
x jeho xxxx (+)
___________________________________________________________________________________________
8 Xxxxxxxxx zinečnatý• 0,5 % Xxxxxxx xxx pro xxxxxxxxxx,
/Xxxxxxxxxx xxxx/* (+) xxxxx se xxxxxxxxx. Zakázán
v xxxxxxxxxxxx xxxxx hygieny.
___________________________________________________________________________________________
9 Anorganické siřičitany 0,2 % x xxxxxxxx xx xxxxx XX2
x xxxxxxxxxxxxxxxxxx
/Xxxxxxxxx sulphites xxx
xxxxxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
10 Xxxxxxxx xxxxx 0,1 % Xxx xxx xxxxxxxxxx, xxxxx
/Xxxxxx iodate/° se oplachují.
___________________________________________________________________________________________
11 Xxxxxxxxxxxx• 0,5 % Xxxxxxxx x xxxxxxxxxxxxxx Xxxxxxxx
/Xxxxxxxxxxxx/* xxxxxxxx (sprejích). chlorbutanol.
___________________________________________________________________________________________
12 Xxxxxxxx 4- 0,4 % xxxx kyselina xxx jeden
-hydroxybenzoová•; xxxxx
/4-Xxxxxxxxxxxxxx 0,8 % xxxx xxxxxxxx pro xxxx
xxxx/°x xxxx xxxx a xxxxxx
xxxxxx (+)
___________________________________________________________________________________________
13 3-Xxxxxx-6-xxxxxx-2,3- 0,6 % x xxxxxxxx xx xxxxxxxx Xxxxxxxx x xxxxxxxxxxxxxx
-xxxxxxx-4X-xxxxx-2,4- xxxxxxxx (xxxxxxxx).
-xxxx•; /Xxxxxx-6-xxxxxx-
-xxxxx-2,4(3X)-xxxxx
(Xxxxxxxxxxxxx xxxx)/°
x jeho xxxx
___________________________________________________________________________________________
14 Xxxxxxxx xxxxxxxx•; 0,5 x xxxxxxxx na xxxxxxxx
/Xxxxxx xxxx/°x xxxx
xxxxx sůl/ (+)
___________________________________________________________________________________________
15 3,3´-Xxxxxx-4,4´- 0,1%
(xxxxx-1,6-xxxxxxxxx)
xxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxxx);
/3,3´-Xxxxxxx-4,4´-
-xxxxxxxxxxxxxxxxxx-
xxxxxxxxxxxxx
(Xxxxxxxxxxxxxxxx/°
x jeho soli xxxxxx
xxxxxxxxxxx•
/xxxxxxxxxxx/°(2-xxxxx-
xxxxxxx-1-xxxxxxxxx)•
___________________________________________________________________________________________
16 Xxxxxxxxxx• /Thiomersal/* 0,007 % (xxxx Xx) xx xxxxx s Xxxxx xxx xxxxxxxxxx k xxxxxx Xxxxxxxx thiomersal.
ostatními sloučeninami xxxxx x xxxxxxxxxx xxx.
xxxxxxxxxx touto xxxxxxxxx
xxxxxxx xxxxxxxxx povolená
koncentrace 0,007 % Xx
___________________________________________________________________________________________
17 Xxxxxxxxxxxxx xxxx• 0,007 % (xxxx Hg) xx xxxxx x Xxxxx pro xxxxxxxxxx x xxxxxx Xxxxxxxx
(xxxxxx xxxxxx) xxxxxxxxx sloučeninami xxxxx x xxxxxxxxxx xxxxx xxx. xxxxxxxxxxxxx
/Xxxxxxxxxxxxxx xxxxx xxxxxxxxxx xxxxx xxxxxxxxx xxxxxxxxxx.
(xxxxxxxxx borate)/° zůstává xxxxxxxxx xxxxxxxx
xxxxxxxxxxx 0,007 % x Hg
___________________________________________________________________________________________
18 Xxxxxxxx xxxx-10-xxxxx•; 0,2 % v xxxxxxxx na xxxxxxxx
/Xxxxx-10-xxxxx xxxx/°
x xxxx xxxx(+)
___________________________________________________________________________________________
19 Hexetidin 0,1 %
/Xxxxxxxxxx/* (+)
___________________________________________________________________________________________
20 5-brom-5-nitro-1,3-dioxan 0,1 % Xxx xx xxxxxxxxxx, xxxxx se
(Bronidox)• /5-Xxxxx-5- xxxxxxxxx.
-xxxxx-1,3-xxxxxxx/° Xxxxxxx xxxxxx nitrosaminů.
___________________________________________________________________________________________
21 Xxxxxxxx /Xxxxxxxx/* (+) 0,1 % Xxxxxxx xxxxxx xxxxxxxxxxx.
___________________________________________________________________________________________
22 2,4-Xxxxxxx-xxxxxx- 0,15 %
xxxxxxx• /2,4-Xxxxxxxx-
xxxxxx xxxxxxx/°(+)
___________________________________________________________________________________________
23 Xxxxxxxxxxxx 0,2 % Xxxxxxxx xxxxxxx: 3,3´,4,4´-
/Triclocarban/* (+) xxxxxxxxxxxxxxxxxxx xxxx než 1
xxx 3,3´,4,4´-tetrachlorazoxy-
benzen xxxx než 1 xxx
___________________________________________________________________________________________
24 4-Xxxxx-x-xxxxxx• 0,2% Xxxxxxx v xxxxxxxxxxxx
/4-Xxxxxx-x-xxxxxx/°(+) xxxxxxxxxxxxxx xx xxxxxxxx
xx xxxxxxxx.
___________________________________________________________________________________________
25. Xxxxxxxxx /Xxxxxxxxx/* (+) 0,3 %
___________________________________________________________________________________________
26 4-Xxxxx-3,5-xxxxxxx(4- 0,5 %
-xxxxx-3,5-xxxxxxxxxxxxx)•
/4-Xxxxxx-3,5-xxxxxxx/°(+)
___________________________________________________________________________________________
27 3,3´-Xxx[1-(xxxxxxx- 0,6 %
xxxxxx)-2,5-xxxxxxxxxx-
xxxxxxx-4-xx]-1,1´-
xxxxxxxxxxxxxxxxxx
(xxxxxxxxxxxxxxxxxxxxxx)•
/3,3´--Xxx(1-xxxxxxx-
xxxxxx-2,5-xxxxxxxxxx-
xxxxxxx-4-xx)-1,1´-xxxxxx-
xxx-xxxxx ("Xxxxxxxxxxxxxx
xxxx") /°(+)
___________________________________________________________________________________________
28 Poly-1-hexamethylen 0,3 %
xxxxxxxx-xxxxxxxxxxxx•
/Xxxx-(1-xxxxxxxxxx-
xxxxxxxxxxx xxxxx-
xxxxxxxx/°(+)
___________________________________________________________________________________________
29 2-Xxxxxxxxxxx-1-xx• 1 %
/2-Xxxxxxxxxxxxxx/°(+)
___________________________________________________________________________________________
30 Xxxxxxxxxxxxxxxxxxxx 0,15 %
(methenamin, xxxxxxxxx)•
/Xxxxxxxxxxxxxxxxxxxxx
(xxxxxxxxxxx*)/°(+)
___________________________________________________________________________________________
31 Xxxxxxxxxx-3-xxxxxx- 0,2 %
-xxxxxxxxxxxx•
/Xxxxxxxxxxx-3-xxxxxx-
xxxxxxxxxxxxx/°(XXXX)
___________________________________________________________________________________________
32 1-(4-Xxxxxxxxxxx)-1- 0,5 %
(xxxxxxxx-1-xx)-3,3´-
xxxxxxxxxxxxx-2-xx•
/1-(4-Xxxxxxxxxxxxx)-
-1-(xxxxxxxx-1-xx)3,3-
-xxxxxxxxxxxxx-2xxx/°
(+)
___________________________________________________________________________________________
33 1,3-Xxx(xxxxxxxxxxxxx)- 0,6 %
-5,5-xxxxxxxxxxxxxxxxxxxx-
2,4-xxxx• /1,3-Xxx
(xxxxxxx-xxxxxx)-5,5-
-xxxxxxxx-xxxxxxxxxxxxx-
-2,4-xxxxx/°(+)
___________________________________________________________________________________________
34 Xxxxxxxxxxxxx• 1 %
/Xxxxxx xxxxxxx/°
___________________________________________________________________________________________
35 1-Hydroxy-4-methyl-6- 1 % Xxx xxxxxxxxxx, xxxxx xx xxxxxxxxx.
(2,4,4-xxxxxxxxxxxxxxx)
xxxxxxx-2(1X)-xx•;
/1-Xxxxxxx-4-xxxxxx-6 0,5 % Xxx xxxxxxx xxxxxxxxxx.
(2,4,4-xxxxxxxxx-xxxxxx)
2-xxxxxxx/°x xxxx
xxxxxxx s xxxxxxxxxx-
xxxxxxx• (xxxxxxxxx) (+)
___________________________________________________________________________________________
36 1,2-Xxxxxx-2,4- 0,1 % Xxxxx pro xxxxxxxxxx, xxxxx
xxxxxxxxxxx• se xxxxxxxxx.
/1,2-Xxxxxxx-2,4-
-xxxxxxxxxxxxx°
XXXXXXXXXXXXX
XXXXXXXXXXXXXX•
___________________________________________________________________________________________
37 6,6´-Xxxxxx-4,4-´xxxxxxx- 0,1 %
-2,2-´xxxxxxxxxxxxxxx•
(Xxxxxxxxxxxxxx)
/6,6-Xxxxxxx-4,4-xxxxxxxx-
2,2-´xxxxxxxxxxxxxxxxx
(Xxxxxxxxxxxxxxx)/°(+)
___________________________________________________________________________________________
38 4-Xxxxxxxxx-x-xxxxxx 0,1 %
(4-xxxxxxxxx-3-xxxxxxxxxxx)•
/4-Xxxxxxxxx-x-xxxxxx/°
___________________________________________________________________________________________
39 Xxxx 5-chlor-2-methyl- 0,0015 % (Směs x xxxxxx 3 :1
-isothiazol-3(2H)-onu• 5-xxxxx-2-xxxxxx-xxxxxxxxxx-3(2X)-
/5-xxxxxx-2-xxxxxxx- -xx x 2-xxxxxxxxxxxxxxxx-3(2X)-xx
xxxxxxxxx-3(2X)-xxx/°x
2-xxxxxxxxxxxxxxxx-3(2X)-
-xxx• /2-xxxxxxxxxxxxxxxx-
3(2X)-xxx/°x xxxxxxxxx
xxxxxxxxxx /xxxxxxxxx
xxxxxxxx/°x xxxxxxxxxx
xxxxxxxxxx /magnesium
nitrate/°
___________________________________________________________________________________________
40 2-Benzyl-4-chlorfenol• 0,2 %
(Xxxxxxxxx) /2-Xxxxxx-4-
-xxxxxxxxxxx
(Xxxxxxxxxxx)/°
___________________________________________________________________________________________
41 Xxxxxxxxxxxxx• 0,3 % Obsahuje
/2-Chloracetamide/° chloracetamid.
___________________________________________________________________________________________
42 Xxxxxxxxxxxx• 0,3 % x xxxxxxxx na xxxxxxxxxxxx
/Xxxxxxxxxxxxx/* x jeho
diglukonát, /digluconate/°,
diacetát /xxxxxxxxx/ a
dihydrochlorid
/dihydrochloride/°(+)
___________________________________________________________________________________________
43 1-Xxxxxxxxxxxx-2-xx• 1,0 % Xxx pro xxxxxxxxxx, xxxxx xx
/1-Xxxxxxxxxxxxx-2-xx/° xxxxxxxxx.
___________________________________________________________________________________________
44 Xxxxx (X12 - X22) 0,1 %
xxxxxxxxxxxxxxxxxxxxxx
x -xxxxxxx•
/Xxxxx (X12 - C22) trimethyl
ammonium-bromide
a xxxxxxxx/°(+)
___________________________________________________________________________________________
45 4,4-Xxxxxxxx-1,3- 0,1 % xX xxxxxxxxx xxxxxxxx xxxxx
-xxxxxxxxxx• /4,4-Xx- xxx xxxxx xxx 6.
xxxxxx-1,3-xxxxxxxxxxx/
___________________________________________________________________________________________
46 1-[1,3-Xxx(xxxxxxx- 0,5 %
-xxxxxx)-2,5-xxxxx-
xxxxxxxxxxxx-4-xx]-1,3-
-xxx(xxxxxxxxxxxxx)
xxxxxxxx•
/X-(Xxxxxxxxxxxxx)-X-
-(xxxxxxxxxxxxxxx-1,3-
-xxxxx-2,5-xxxxxxxxxxx-
xxx-4)X´-(xxxxxxx-
xxxxxx)xxxx/
___________________________________________________________________________________________
47 4,4-´(Xxxxx-1,6-xxxxxx- 0,1 %
xxx)xxxxxxxxxxxxxx•
/1,6-Xx(4-xxxxxxxxxxxx-
xx)-x-xxxxxx(Xxxxxxxx-
xx)/°x xxxx soli xxxxxx
xxxxxxxxxxx (2-hydroxy-
-ethan-1-sulfonátu)•
/isethionate/°a 4-xxxxx-
xxxxxxxxxx• /x-xxxxx-
xxxxxxxxxx/°(+)
___________________________________________________________________________________________
48 Xxxxxxxxxxxxxx 0,1 % Xxxxxxxx x rozprašovačích Obsahuje
(pentandial)• xxxxxxxx (xxxxxxxx). xxxxxxxxxxxxx.
/Xxxxxxxxxxxxx (při xxxxxx
(Xxxxxxx-1,5-xxxx)/° xxxxxxxxxxxxxx x
xxxxxxxx produktu
vyšším než 0,05 %)
___________________________________________________________________________________________
49 5-Ethyl-3,7-dioxa-1- 0,3 % Xxxxxxx x xxxxxxxxxxxx xxxxx
-xxxxxxxxxx[3.3.0]xxxxx• xxxxxxx a x xxxxxxxxxxxx
/5-Xxxxx-3,7-xxxxx-1- xxxxxxxxxxxxxx do xxxxxxxx
-xxxxxxxxxx[3.3.0] xx sliznicí.
octane/°
___________________________________________________________________________________________
50 3-(4-Xxxxxxxxxxx)-xxxxxx- 0,3 %
-1,2xxxx• (Xxxxxxxxxxxx)
/3-(x-Xxxxxxxxxxxx)-
-xxxxxxx-1,2-xxxx
(Xxxxxxxxxxxxx)/°
___________________________________________________________________________________________
51 [(Xxxxxxxxxxxxx)xxxxx] 0,5 %
xxxxxx xxxxx, X-(xxxxxxx-
xxxxxx)-xxxxxxxx xxxxx,•
/Xxxxxx xxxxxxxxxxxxxx-
xxxxxxxxxxx, (Xxxxxx
xxxxxxxxxxxxxxxxxxxxxx)/°
___________________________________________________________________________________________
52 Xxxxxxx xxxxxxxx xxxxx- 0,004 % v xxxxxxxx xx XxXx 20 % (hmotn.)AgCl na XxX2
xxxx xx xxxxx xxxxxxxxxxx Xxxxxxx x xxxxxxxxxxxx pro xxxx xx
/Xxxxxx chloride deposited 3 xxx, v xxxxxxxxxxxx ústní hygieny
on Xxxxxxxx dioxide/° a x xxxxxxxxxxxx aplikovaných do
okolí xxx x xx xxx.
___________________________________________________________________________________________
53 Benzyl{2-[2-(diisobutylfe- 0,1 % x) prostředky, xxxxx xx xxxxxxxxx;
xxxx)xxxxxx]xxxxx}xx- x) prostřeky, xxxxx zůstávají na xxxx, xxxxx xxxxxxxxxx
xxxxxxxxxxxxx-xxxxxxx xxx xxxx x xxxxxx xxxxx
Xxxxxxxxxxxx-xxxxxxx•
XXXXXXXXXXXX XXXXXXXX°
___________________________________________________________________________________________
54 Xxxxx(X8 - X18) (xxxxxx) 0,1 % x xxxxxxxx xx Xxxxxxx xxxxx x xxxxx.
xxxxxxxxxxxxxxx-xxxxxxx, xxxxxxxxxxxx-xxxxxxx
-xxxxxx x xxx s xxxxxxxx
xxxxxxxxx (xxxxxxxxxxxx
-xxxxxxx, -xxxxxx x xxx s
cukernou xxxxxxxxx)•
/Xxxxxxxxxxxx xxxxxxxx,
xxxxxxx and
saccharinate/°(+)
___________________________________________________________________________________________
55 Benzylhemiformal 0,15 % Xxx xxx xxxxxxx, xxxxx xx
(xxxxxxxxxxxxxxxxx)• xxxxxxxxxx xxxxxxxxxxxx.
/Xxxxxxxxxxxxxxxx/°
___________________________________________________________________________________________
56 3-Xxxxxxx-2-xx-1-xx-X- 0,05 % 1. Nesmí xx používat v Xxxxxxxx jod.
-butylkarbamát• xxxxxxxxxxxx xxxxx xxxxxxx x x
/3-Xxxx-2-xxxxxxxx-xxxxx- xxxxxxxxxxxx x xxxx o xxx.
xxxxxxxxx/° 2. Pokud xxxxxxxxxxx v
prostředcích, xxxxx xxxx určeny
k tomu, xxx xxxxxxxxx xx
xxxxxxx, xxxxxxxx 0,02 %,
xxxxxxxx xxxx: Xxxxxxxx jod.
___________________________________________________________________________________________
57 2-methylisothiazol- 0,01 %
-3(2X)-xx•
XXXXXXXXXXXXXXX-
XXXXXX°
___________________________________________________________________________________________
(1) Platí xxxxx xxx výrobky, xxxxx xx mohly být xxxxxxx xxx xxxx xx 3 xxx x xxxxx xxxxxxxxx x prodlouženém xxxxxxxx x xxxx.
(*) V xxxx xxxxxxx xx xxxxx xxxxxxxx xxxxxxx xxxxx xxxxxxxxxxx x xxxxxxx xxxxxxxxxxx xxxxxxxxxxxx xxxxx pro xxxxxxxxxxxxx xxxxxxx "Xxxxxxxx xxxxx-xxx 1975, International Xxx-xxxxxxxxxxx Xxxxx (INN) xxx xxxxxxxxxxxxxx xxxxxxxx Xxxxx 1,33 of xxxxxxxx XXX", XXX, Xxxxxx, Xxxxxx 1975.
(•) X xxxx xxxxxxx xx xxxxx xxxxxxxx označen xxxxx xxxxxxxxx xxxxx "Xxxxxxxx xxxxxxxxxxx xxxxxxxxxxx xxxxxxxxx podle IUPAC (Xxxxxxxxxx 1993)", Academia, Xxxxx 2000.
(°) X xxxx xxxxxxx xx xxxxx xxxxxxxx xxxxxxx xxxxx x xxxxxxxxx xxxxxx, xxxxxxxx x xxxxxxxxx "The Cosmetics Xxxxxxxxx 76/768/XXX", Colipa, Xxxxxxxx, Xxxxx 2000.
Xxxx 2
Xxxxxx xxxxxxxxxxxxx xxxxxx xxxxxxx povolených x xxxxxxxxxxxx prostředcích, xxxxxxxx xxxxxxxxx xxxxxxxxxxx, xxxxxxxxx xx čistotu xxxxxxxxx xxxxxxxxxxxxx přísad x xxxxxxxx xxxxxxx
_______________________________________________________________________________________
Xxx. xxxxx Xxxxx Xxxxxxxxx Xxxxxxx a Podmínky xxxxxxx x xxxxxxxx,
xxxxxxxx xxxxxxxxx xxxxx xxxx být xxxxxxxxx xx
xxxxxxxxxxx xxxxx
_______________________________________________________________________________________
x b c x x
_______________________________________________________________________________________
_______________________________________________________________________________________
_______________________________________________________________________________________
Xxxxxxxx: V xxxxxxxx xxxx tato xxxxxxx xxxxxxxxxx žádnou xxxxx.